pterygium
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 18-70 years old, gender is not limited, diagnosed as primary pterygium; (2) Voluntary to the study; (3) be able to follow and complete the follow-up plan; (4) Patients with pterygium that affects appearance or vision.
Exclusion criteria
Exclusion criteria: (1) Diplopterygium, pseudopterygium, recurrent pterygium; (2) Patients with a history of abnormal coagulation function and rheumatic immune system diseases; (3) Patients with ocular surface diseases such as blepharitis, Sjogren's syndrome and dry eye, chronic dacryocystitis; (4) Pregnant and lactating patients; (5) Patients with allergies; (6) Those who are unwilling to participate in this clinical trial; (7) Long-term history of topical ocular medication; (8) active inflammation (systemic or eye); (9) Combined with other major diseases of the eye (glaucoma, retinal detachment, macular hemorrhage, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Conjunctival graft stability; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative inflammation;Postoperative discomfort symptoms;Patient satisfaction;complication;Pterygium recurrence rate; | — |
Countries
China
Contacts
Department of Ophthalmology, Huadong Hospital, Fudan University